Is the US prepared to deal with another pandemic or widespread health crisis?
The US is better prepared in several technical and material areas than it was before COVID-19, but significant gaps remain in coordination, sustained funding, workforce, public trust, local capacity, and political consistency, leaving it not fully ready for another severe pandemic or widespread health crisis. Assessments from bipartisan commissions, government watchdogs, the WHO, CDC, and others consistently describe progress mixed with persistent vulnerabilities.[1][2]
Key Improvements Post-COVID
The Biden-Harris administration (and ongoing efforts) invested heavily in rebuilding after COVID-19 exposed major shortfalls:
These steps have enabled quicker responses to threats like H5N1 (stockpiling vaccines, monitoring), mpox, Marburg/Ebola support abroad, and routine respiratory seasons.
Persistent Gaps and Vulnerabilities
Experts emphasize that preparedness is incomplete and fragile:
Bottom Line
The US has stronger stockpiles, better data/surveillance tools, advanced R&D platforms, and institutional learning than pre-2020, enabling faster initial responses to known or similar threats. It is not starting from the same low base. However, it is not fully prepared for a high-severity, novel, or rapidly escalating crisis due to coordination fragmentation, uneven local readiness, workforce/trust issues, funding volatility, and incomplete implementation of lessons. A moderate flu-like event might be managed better; a COVID-scale or worse event (higher lethality, more disruptive) would still strain systems heavily.[9]
Preparedness is ongoing, not a destination—it requires consistent bipartisan investment, leadership, exercises, and addressing root issues like healthcare capacity and social determinants. Ongoing threats (avian flu, other zoonoses, antimicrobial resistance, potential bioweapons) underscore the urgency. Independent reviews (Commission, GAO, JEE) provide clear roadmaps; execution and sustained political will determine outcomes.
Citations (15)
- https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/
Backs: “Assessments from bipartisan commissions, government watchdogs, the WHO, CDC, and others consistently describe progress mixed with persistent vulnerabilities.”
- https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/
Backs: “Assessments from bipartisan commissions, government watchdogs, the WHO, CDC, and others consistently describe progress mixed with persistent vulnerabilities.”
- https://aspr.hhs.gov/SNS/Pages/Stockpile-Responses.aspx
Backs: “Sustainment includes quality checks, shelf-life extensions, and efforts to push stockpiles closer to state/local levels.”
- https://www.aspr.gov/news-updates/blog/2025-12/stand-ready-move-fast-save-lives
Backs: “Sustainment includes quality checks, shelf-life extensions, and efforts to push stockpiles closer to state/local levels.”
- https://www.cdc.gov/washington/testimony/2024/t20241114.htm
Backs: ““Warm base” partnerships with clinical labs aim for faster test development and surge capacity.”
- https://www.niaid.nih.gov/news-events/nih-awards-establish-pandemic-preparedness-research-network
Backs: “Investments in domestic manufacturing aim to reduce supply-chain risks.”
- https://www.who.int/publications/i/item/9789240105409
Backs: “It scored highly in areas like labs, surveillance foundations, and some emergency management, reflecting investments.”
- https://biodefensecommission.org/wp-content/uploads/2024/05/National-Blueprint-for-Biodefense-2024_final_.pdf
Backs: “Biological threats (natural, accidental, deliberate) are growing.”
- https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/
Backs: “Funding and milestones often lack clear ties to risk reduction.”
- https://www.gao.gov/products/gao-25-107588
Backs: “Funding and milestones often lack clear ties to risk reduction.”
- https://www.gao.gov/products/gao-25-106980
Backs: “Funding and milestones often lack clear ties to risk reduction.”
- https://manhattan.institute/article/are-us-health-agencies-prepared-for-the-next-pandemic
Backs: “Global contributions (Pandemic Fund, CEPI) have seen pledges but face congressional and administrative hurdles.”
- https://www.kff.org/public-opinion/kff-health-tracking-poll-ebola-pandemic-preparedness/
Backs: “Supply chains, hospital surge capacity, and novel pathogen “Pathogen X” readiness still have risks.”
- https://www.notus.org/health-science/white-house-pandemic-preparedness
Backs: “Supply chains, hospital surge capacity, and novel pathogen “Pathogen X” readiness still have risks.”
- https://www.bloomberg.com/news/articles/2026-06-11/is-the-us-prepared-for-the-next-pandemic-how-trump-s-policies-weakened-defenses
Backs: “Supply chains, hospital surge capacity, and novel pathogen “Pathogen X” readiness still have risks.”